Overview
Beijing GoBroad Hospital is a leading private research-oriented hospital and flagship institution of the GoBroad Healthcare Group, established in 2017. Located in Changping Life Science Park, Beijing, the hospital officially opened in July 2023 and specializes in solid tumors, hematologic tumors, and brain science. It is renowned as one of China's top centers for CAR-T cell immunotherapy and hematopoietic stem cell transplantation (bone marrow transplant), treating patients with lymphoma, myeloma, leukemia, and other challenging hematologic cancers. The hospital integrates clinical research, precision diagnostics, and innovative cellular therapies, with more than half of its team dedicated to clinical innovation. For international patients from 12+ countries, the hospital operates a dedicated International Patient Service Center providing end-to-end support including medical visa guidance, airport transfers, multilingual coordination, and international insurance assistance, achieving a 95% patient satisfaction rate.